Cargando…
Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation
Phillygenin, as an active ingredient of Forsythia suspensa, possesses a wide range of biological and pharmacological activity. However, its development and application are restricted due to its poor bioavailability and low solubility. Our work aimed to develop a self-microemulsifying drug delivery s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076376/ https://www.ncbi.nlm.nih.gov/pubmed/32028742 http://dx.doi.org/10.3390/pharmaceutics12020130 |
_version_ | 1783507202289434624 |
---|---|
author | Wang, Lingzhi Yan, Wenrui Tian, Yurun Xue, Huanhuan Tang, Jiankai Zhang, Liwei |
author_facet | Wang, Lingzhi Yan, Wenrui Tian, Yurun Xue, Huanhuan Tang, Jiankai Zhang, Liwei |
author_sort | Wang, Lingzhi |
collection | PubMed |
description | Phillygenin, as an active ingredient of Forsythia suspensa, possesses a wide range of biological and pharmacological activity. However, its development and application are restricted due to its poor bioavailability and low solubility. Our work aimed to develop a self-microemulsifying drug delivery system to improve the oral bioavailability of phillygenin. The composition of the self-microemulsifying drug delivery system was preliminary screened by the pseudo-ternary phase diagram. Subsequently, the central composite design method was employed to optimize the prescription of the self-microemulsifying drug delivery system loaded with phillygenin. The prepared self-microemulsifying drug delivery system of phillygenin was characterized in terms of morphology, droplet size distribution, polydispersity index and stability. Then, the in vitro dissolution and the oral bioavailability were analyzed. The optimized self-microemulsifying drug delivery system of phillygenin consisted of 27.8% Labrafil M1944CS, 33.6% Cremophor EL, 38.6% polyethylene glycol 400 (PEG-400) and 10.2 mg/g phillygenin loading. The prepared self-microemulsifying drug delivery system of phillygenin exhibited spherical and uniform droplets with small size (40.11 ± 0.74 nm) and satisfactory stability. The in vitro dissolution experiment indicated that the cumulative dissolution rate of the self-microemulsifying drug delivery system of phillygenin was significantly better than that of free phillygenin. Furthermore, after oral administration in rats, the bioavailability of phillygenin was significantly enhanced by the self-microemulsifying drug delivery system. The relative bioavailability of the self-microemulsifying drug delivery system of phillygenin was 588.7% compared to the phillygenin suspension. These findings suggest that the self-microemulsifying drug delivery system of phillygenin can be a promising oral drug delivery system to improve the absorption of phillygenin. |
format | Online Article Text |
id | pubmed-7076376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70763762020-03-24 Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation Wang, Lingzhi Yan, Wenrui Tian, Yurun Xue, Huanhuan Tang, Jiankai Zhang, Liwei Pharmaceutics Article Phillygenin, as an active ingredient of Forsythia suspensa, possesses a wide range of biological and pharmacological activity. However, its development and application are restricted due to its poor bioavailability and low solubility. Our work aimed to develop a self-microemulsifying drug delivery system to improve the oral bioavailability of phillygenin. The composition of the self-microemulsifying drug delivery system was preliminary screened by the pseudo-ternary phase diagram. Subsequently, the central composite design method was employed to optimize the prescription of the self-microemulsifying drug delivery system loaded with phillygenin. The prepared self-microemulsifying drug delivery system of phillygenin was characterized in terms of morphology, droplet size distribution, polydispersity index and stability. Then, the in vitro dissolution and the oral bioavailability were analyzed. The optimized self-microemulsifying drug delivery system of phillygenin consisted of 27.8% Labrafil M1944CS, 33.6% Cremophor EL, 38.6% polyethylene glycol 400 (PEG-400) and 10.2 mg/g phillygenin loading. The prepared self-microemulsifying drug delivery system of phillygenin exhibited spherical and uniform droplets with small size (40.11 ± 0.74 nm) and satisfactory stability. The in vitro dissolution experiment indicated that the cumulative dissolution rate of the self-microemulsifying drug delivery system of phillygenin was significantly better than that of free phillygenin. Furthermore, after oral administration in rats, the bioavailability of phillygenin was significantly enhanced by the self-microemulsifying drug delivery system. The relative bioavailability of the self-microemulsifying drug delivery system of phillygenin was 588.7% compared to the phillygenin suspension. These findings suggest that the self-microemulsifying drug delivery system of phillygenin can be a promising oral drug delivery system to improve the absorption of phillygenin. MDPI 2020-02-03 /pmc/articles/PMC7076376/ /pubmed/32028742 http://dx.doi.org/10.3390/pharmaceutics12020130 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wang, Lingzhi Yan, Wenrui Tian, Yurun Xue, Huanhuan Tang, Jiankai Zhang, Liwei Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation |
title | Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation |
title_full | Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation |
title_fullStr | Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation |
title_full_unstemmed | Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation |
title_short | Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation |
title_sort | self-microemulsifying drug delivery system of phillygenin: formulation development, characterization and pharmacokinetic evaluation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076376/ https://www.ncbi.nlm.nih.gov/pubmed/32028742 http://dx.doi.org/10.3390/pharmaceutics12020130 |
work_keys_str_mv | AT wanglingzhi selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation AT yanwenrui selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation AT tianyurun selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation AT xuehuanhuan selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation AT tangjiankai selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation AT zhangliwei selfmicroemulsifyingdrugdeliverysystemofphillygeninformulationdevelopmentcharacterizationandpharmacokineticevaluation |